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We aimed to evaluate technical aspects and the clinical relevance of a simultaneous confocal scanning laser ophthalmoscope and a
high-speed,high-resolution,spectral-domainopticalcoherencetomography(SDOCT)deviceforretinalimaging.Theprincipleof
confocal scanning laser imaging provides a high resolution of retinal and choroidal vasculature with low light exposure. Enhanced
contrast, details, and image sharpness are generated using confocality. The real-time SDOCT provides a new level of accuracy
for assessment of the angiographic and morphological correlation. The combined system allows for simultaneous recordings
of topographic and tomographic images with accurate correlation between them. Also it can provide simultaneous multimodal
imaging of retinal pathologies, such as ﬂuorescein and indocyanine green angiographies, infrared and blue reﬂectance (red-free)
images, fundus autoﬂuorescence images, and OCT scans (Spectralis HRA+OCT; Heidelberg Engineering, Heidelberg, Germany).
The combination of various macular diagnostic tools can lead to a better understanding and improved knowledge of macular
diseases.
1.Introduction
With the advent of novel technologies, both optical coher-
ence tomography (OCT) and confocal scanning laser oph-
thalmoscopy (cSLO) have been introduced successfully into
the routine clinical imaging for a wide spectrum of macular
diseases. The combination of these two techniques in one
instrument, which oﬀers various subsequent advantages,
including exact correlation of tomographic and topographic
ﬁndings, has the potential to enhance further our under-
standing of disease pathogenesis, diagnosis, and patient
management.
In this paper, we aimed to review the history, some
of the technical aspects, and important clinical applica-
tions of a high-speed, high-resolution spectral-domain OCT
(SDOCT) device which also is able to combine cSLO-based
ﬂuorescein and indocyanine green angiograms, infrared,
blue reﬂectance (“red-free”), and fundus autoﬂuorescence
(FAF) images.
2. History
Based on the pioneering work of Webb et al. [1, 2],
confocal scanning laser ophthalmoscopes (cSLOs) have been
developed for clinical use. Although limited by the optical
properties of the human eye, they are able to achieve
high-contrast images of the posterior segment. Today most
scanning laser systems record their images in real time with a
fast frame rate.
Optical coherence tomography was initially reported by
Huang and coworkers in 1991 [3]a n dh a sh a dat r e m e n d o u s
subsequent impact on in vivo imaging of retinal diseases.
It has evolved as a noninvasive technique and allows for
visualization of microstructural alterations of the retinal2 Journal of Ophthalmology
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Figure 1: Example of a normal eye imaged with the Spectralis SDOCT. The infrared reﬂectance cSLO image (lower left) shows a normal
fundus which corresponds to the normal SDOCT B-scan. The green lines represent the location, and the green arrow shows the exact
orientation of the B-scan. All the retinal layers are indicated on the SDOCT scan (ILM: internal limiting membrane; NFL: nerve ﬁber layer;
GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; ELM:
external limiting membrane; IS/OS: photoreceptor inner/outer segment junction; RPE: retinal pigment epithelium).
tomographic architecture. This imaging modality is now
used widely by ophthalmologists for a range of indications
and has become a standard diagnostic technique [4–16]. It
provides images analogous to ultrasonography, but, instead
of sound, it uses light waves to obtain a reﬂectivity proﬁle
of the tissue under investigation, measuring the time delay
and magnitude of backscattered or reﬂected light by low-
coherence interferometry.
The OCT technique available most widely in clinical
practice is referred to as time-domain OCT, because the
depth information of the retina is acquired as a sequence
of samples over time. This can be performed either in
longitudinal cross-sections perpendicular to or in the coro-
nal plane parallel to the retinal surface. Recently, major
advances have been made regarding the image resolution—
notably the development of a high-resolution OCT—and
in imaging speed, signal-to-noise ratio, and sensitivity with
the introduction of an ultrahigh-resolution SDOCT [17–
24]. In time-domain OCT and earlier ultrahigh-resolution
OCT, referencemirrors move mechanically,limiting imaging
speed. In SDOCT, the reference mirror is stationary and
the OCT signal is acquired either by using a spectrometer
as a detector or by varying the narrowband wavelength of
the light source in time (swept source). Echo time delays of
light are measured by acquiring the interference spectrum
of the light signal and taking its Fourier transform [25,
26]. Increasing imaging speed allows for the acquisition of
images within a fraction of second, thus minimizing motion
artifacts [27]. It has also become possible to acquire three-
dimensional volume OCT scans that achieve comprehensive
retinal coverage [28].
The combination of OCT and cSLO in one instru-
ment oﬀers a number of subsequent advantages, including
an accurate correlation of tomographic with topographic
architecture of the retina, which opens new insights in
the pathogenesis and morphological alterations of retinal
diseases [29, 30]. Additionally a multimodality imaging
system provides a complete view of the vitreous, retina
and choroid, enabling clinicians to combine information
from six diﬀerent modes to assess the eye: ﬂuorescein and
indocyanine green angiographies, FAF, infra-red, red-free,
and SD-OCT. Simultaneous high-resolution fundus imaging
and SD-OCT with the Spectralis (Heidelberg Engineering,
Heidelberg, Germany) oﬀer high-quality images with the
certainty of knowing the location, leading to a signiﬁcantly
better diagnosis and monitoring of the patient (Figure 1).
3.TechnicalAspects
The imaging system cSLO/OCT (Spectralis HRA+OCT)
combines high speed, high-resolution SDOCT images with
simultaneous recording of ﬂuorescein and indocyanine-
green angiographies, digital infrared and blue reﬂectance, or
FAF images. On the other hand, the Spectralis OCT has only
twomodes—SDOCT andinfrared.BothSDOCTdevicesuse
a new proprietary eye-tracking technology, which locks onto
a speciﬁc location on the retina and relocates the site at
laterexamstoenhancethemonitoring ofdiseaseprogression
and treatment decisions. For image clarity, the proprietary
Heidelberg Noise Reduction feature takes the axial reso-
lution from 7 microns to 3.5 microns. And the device
dual-beam imaging captures a reference scan and cross-
section simultaneously for reliably accurate registration.
Regarding the technical parameters of the SDOCT, 40000
A-scans are acquired per second using an optical resolution
of approximately 7mm in depth (axial resolution) and
14mm transversally (lateral optical resolution). The centre
wavelength of the OCT light source is typically between 870
and880nm.OCTscanscanberecordedsimultaneouslywith
ﬂuorescein angiography, indocyanine-green angiography,
FAF, infrared, and blue reﬂectance images. For the A-scans
the scan depth is 1.8mm/512 pixels, providing a digital axial
resolution of 3.5µm/pixel. Spectralis scans 100 times faster
than time-domain OCT and 40% faster than most otherJournal of Ophthalmology 3
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Figure 2: A 71-year-old man with a pigment epithelial detachment in the presence of neovascular AMD in the right eye. In the SDOCT scan
the pigment epithelial detachment is readily visualized underneath the fovea associated with intraretinal cysts and subretinal ﬂuid. It is also
possible to identify the subretinal neovascular membrane and the vitreoretinal interface.
SDOCT instruments. B-scans cover a transversal range of
15, 20, or 30◦ ﬁeld of view. In the high-speed mode scan
widths are 384, 512, and 768 A-scans per B-scan with a
lateral digital resolution of 11µm/pixel and a scan rate of
89, 69 and 48 B-scans/second, respectively. In the high-
speed mode, the vertical presentation of the OCT scan
is magniﬁed twice; therefore morphological alterations are
presented disproportionately high in the vertical dimension.
The accelerated imaging speed allows the acquisition of an
image within a fraction of second, thus minimizing motion
artefacts. Vertical and horizontal OCT scans are placed in the
area of interest.
The high-resolution modes encompass a scan width of
768, 1024, and 1.536 A-scans per B-scan with a lateral digital
resolution of 5µm/pixel at a scan rate of 48, 37, and 25
B-scans/second, respectively. High-resolution fundus images
provide clear cross-sectional scans of the retinal anatomical
structure, including the retinal surface, intraretinal alter-
ations, as well as subretinal morphologic pathologies.
Sequences of B-scans can be acquired to image a full
volume. These volume scans can be obtained at 15, 20 and
30◦ ﬁeld of view. The number of B-scans per volume can
be adjusted from 12 to 96 B-scans per 10◦. In addition, it
is also possible to acquire 3D volumetric OCT scans for
comprehensive analysis of the entire retina and, therefore,
for 3D mapping of pathologic alterations within the retinal
layers including the RPE.
4. ClinicalApplications
The new technology of the SDOCT has improved the
visualization of intraretinal morphologic features allowing
the evaluation of the integrity of each retinal layer and in
vivo visualization of microstructural morphology of the
retina. The high-speed, high-resolution SDOCT (Spectralis)
has been applied over the last few years to investigate
morphological substrates for alterations in eyes with various
macular disorders.
One of the most important clinical applications of this
device is to help guiding diagnosis and treatment of patients
with age-related macular degeneration (AMD). In early
stages of AMD, drusen can be detected at their speciﬁc
location [29]. Small drusen appears as localized detachments
of the retinal pigment epithelium (RPE) with intact layered
architecture of the photoreceptor segments. In large drusen,
RPE elevation and derangement can be seen in association
with a disrupted photoreceptor band. Additionally in cases
of reticular drusen, another example of early AMD, the
SDOCT scan shows alterations in the outer retinal and RPE
layers. These ultrastructural characteristics may allow dis-
tinguishing subclasses of drusen and may allow identifying
biomarkers for disease severity or risk of progression [31]. In
cases of dry AMD with geographic atrophy, SDOCT scans
also can conﬁrm loss of the RPE monolayer along with
atrophy of the outer neurosensory retinal layers. In most
eyes with geographic atrophy the inner retinal layers are
unchanged, whereas the outer retinal layers show alterations
in all eyes. SDOCT provides adequate resolution for quanti-
fying photoreceptor loss and allows visualization of reactive
changes in the RPE cells in the junctional zone of geographic
atrophy [30, 32, 33]. Finally SDOCT scans can be useful to
delimitate and better visualize areas of pigment epithelium
detachments (PEDs) and choroidal neovascular membranes
in cases of wet or exudative AMD (Figure 2). The combi-
nation of the FA and the SDOCT with high-resolution and
real-time mean image elaboration may enhance the detailed
visualization of activity in new choroidal neovascularization,
such as presence of subretinal, intraretinal, or sub-RPE ﬂuid,
intraretinal cysts, or a combination of them [34, 35]. The
high sensitivity on neovascular activity expressed by the
SDOCT features may be helpful in clinical practice, reducing
the need of angiographies for treatment decisions [36].
It is well known that OCT imaging in patients with
diabetic macular edema is able to reveal several structural
changes in the retina, such as epiretinal membranes,
intraretinal and subretinal ﬂuid, and cystoid macular edema
[37, 38]. It is a very useful tool for diagnosis, especially in
challenging cases, and treatment followup. Only a limited
number of studies using diﬀerent SDOCT devices for
assessing diabetic macular edema and diabetic retinopathy
have been published [39–42]. In cases of diabetic macular
edema, SDOCT has enabled us to analyze with more details
the integrity of the outer retinal layers, which includes the
external limiting membrane, the photoreceptors junction,
the RPE, and Bruch’s membrane. One ﬁrst report using the
Spectralis SDOCT showed the importance of the integrity4 Journal of Ophthalmology
of the external limiting membrane and the photoreceptors
junction as a prognostic feature of visual improvement after
treatment for diabetic macular edema [42].
Spectral-domain OCT has dramatically improved the
visualization of the vitreomacular interface and posterior
hyaloid membrane and has become a very important tool for
the diagnosis and followup of patients with alterations of the
vitreoretinal interface. In cases of epiretinal membranes and
macular pucker, vitreoretinal adhesions at the peak elevation
and retinal wrinkling can be seen in the cSLO image. In the
correspondent SDOCT cross-sectional image the wrinkling
of the inner retinal surface and thickening of the neurosen-
sory retina, particularly pronounced in the outer nuclear
layerandtheinnermostneurosensorylayers,canbeobserved
[29]. Also, in cases of macular hole, besides other features
that have been well described, SDOCT can demonstrate
disruption of photoreceptors junction and imaging this
structure is a method of assessing structural integrity of the
photoreceptors before and after macular hole surgery [43].
The Spectralis SDOCT is a very useful tool for other mac-
ular pathologies, such as retinal vascular occlusive diseases
with macular involvement, central serous chorioretinopathy,
maculardystrophies,idiopathicperifovealtelangiectasia,and
chloroquine retinopathy. There are few studies published in
the literature showing its clinical applications. Important
advantages with clinical signiﬁcance of this new technology
compared to the time-domain technology are the ability
to better visualize the vitreoretinal interface and outer
retinal layers, especially the photoreceptors junction, and the
possibility to obtain 3-dimensional scans allowing to image
structuralchangesofthevitreoretinalinterfaceandtheretina
in large areas.
One advantage of the Spectralis OCT is the improved
visualization of the choroid. Margolis and Spaide [44]
described the measurement of the choroidal thickness using
the enhanced depth imaging technique. It is described by
positioning the device close enough to the eye to acquire
an inverted image within a 5 × 30-degree area centered at
the fovea and then performing manual measurements from
the outer border of the RPE to the inner scleral border. In
the normal studied eyes, the subfoveal choroid was thickest
and grew thinner at more peripheral measurement points.
Alsochoroidalthicknessdemonstratedanegativecorrelation
with age. In diﬀerent reports using the same technique,
the author reported enhanced depth imaging of choroidal
changes underneath a pigmented epithelial detachment in
patients with exudative AMD,thus describing a novel disease
entity termed age-related chorioretinal atrophy [45, 46].
The ability to visualize and quantify choroidal thickness is
a very interesting area of research and may be limited to
a few SDOCT devices which can overcome the technical
limitations of imaging deeper structures such as analog-
to-digitalconversion,wavelength-dependentlightscattering,
and signal loss in the image path before Fourier transforma-
tion.
In conclusion, the combined cSLO/OCT system allows
simultaneous recording and interpolation of topographic
and tomographic images. Diﬀerent cSLO imaging modes
including infrared and blue reﬂectance, FAF and ﬂuorescein
or ICG angiography can be combined with simultaneous
acquisition of OCT. This multimodality combination allows
for a better understanding of the pathogenesis of several
macular pathologies and improvement of diagnosis and
management of patients with macular diseases.
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